Global Prothrombin Complex Concentrate (PCC) Drug Supply, Demand and Key Producers, 2023-2029
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available. It may also be used in those with not enough of these factors due to other reasons such as warfarin therapy. It is given by slow injection into a vein.
This report studies the global Prothrombin Complex Concentrate (PCC) Drug production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Prothrombin Complex Concentrate (PCC) Drug, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Prothrombin Complex Concentrate (PCC) Drug that contribute to its increasing demand across many markets.
The global Prothrombin Complex Concentrate (PCC) Drug market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
In Europe and United States market, key players of prothrombin complex concentrate (PCC) drug include CSL Behring, Grifols, Octapharma, Prothya Biosolutions, Takeda, etc. The top one player hold a share about 58%. United States is the largest market, has a share about 47%, followed by Germany, and France, with share 13% and 12%, separately.
Highlights and key features of the study
Global Prothrombin Complex Concentrate (PCC) Drug total production and demand, 2018-2029, (K Units)
Global Prothrombin Complex Concentrate (PCC) Drug total production value, 2018-2029, (USD Million)
Global Prothrombin Complex Concentrate (PCC) Drug production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Prothrombin Complex Concentrate (PCC) Drug consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Prothrombin Complex Concentrate (PCC) Drug domestic production, consumption, key domestic manufacturers and share
Global Prothrombin Complex Concentrate (PCC) Drug production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Prothrombin Complex Concentrate (PCC) Drug production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Prothrombin Complex Concentrate (PCC) Drug production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Prothrombin Complex Concentrate (PCC) Drug market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include CSL Behring, Grifols, Octapharma, Prothya Biosolutions and Takeda, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Prothrombin Complex Concentrate (PCC) Drug market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Prothrombin Complex Concentrate (PCC) Drug Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Prothrombin Complex Concentrate (PCC) Drug Market, Segmentation by Type
Beriplex
Profilnine
Octaplex
Prothromplex
Cofact
Other
Global Prothrombin Complex Concentrate (PCC) Drug Market, Segmentation by Application
Hemophilia B
Acquired Coagulation Factor Deficiency
Companies Profiled:
CSL Behring
Grifols
Octapharma
Prothya Biosolutions
Takeda
Key Questions Answered
1. How big is the global Prothrombin Complex Concentrate (PCC) Drug market?
2. What is the demand of the global Prothrombin Complex Concentrate (PCC) Drug market?
3. What is the year over year growth of the global Prothrombin Complex Concentrate (PCC) Drug market?
4. What is the production and production value of the global Prothrombin Complex Concentrate (PCC) Drug market?
5. Who are the key producers in the global Prothrombin Complex Concentrate (PCC) Drug market?
6. What are the growth factors driving the market demand?
1 Supply Summary
1.1 Prothrombin Complex Concentrate (PCC) Drug Introduction
1.2 World Prothrombin Complex Concentrate (PCC) Drug Supply & Forecast
1.2.1 World Prothrombin Complex Concentrate (PCC) Drug Production Value (2018 & 2022 & 2029)
1.2.2 World Prothrombin Complex Concentrate (PCC) Drug Production (2018-2029)
1.2.3 World Prothrombin Complex Concentrate (PCC) Drug Pricing Trends (2018-2029)
1.3 World Prothrombin Complex Concentrate (PCC) Drug Production by Region (Based on Production Site)
1.3.1 World Prothrombin Complex Concentrate (PCC) Drug Production Value by Region (2018-2029)
1.3.2 World Prothrombin Complex Concentrate (PCC) Drug Production by Region (2018-2029)
1.3.3 World Prothrombin Complex Concentrate (PCC) Drug Average Price by Region (2018-2029)
1.3.4 North America Prothrombin Complex Concentrate (PCC) Drug Production (2018-2029)
1.3.5 Europe Prothrombin Complex Concentrate (PCC) Drug Production (2018-2029)
1.3.6 China Prothrombin Complex Concentrate (PCC) Drug Production (2018-2029)
1.3.7 Japan Prothrombin Complex Concentrate (PCC) Drug Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Prothrombin Complex Concentrate (PCC) Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Prothrombin Complex Concentrate (PCC) Drug Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 Demand Summary
2.1 World Prothrombin Complex Concentrate (PCC) Drug Demand (2018-2029)
2.2 World Prothrombin Complex Concentrate (PCC) Drug Consumption by Region
2.2.1 World Prothrombin Complex Concentrate (PCC) Drug Consumption by Region (2018-2023)
2.2.2 World Prothrombin Complex Concentrate (PCC) Drug Consumption Forecast by Region (2024-2029)
2.3 United States Prothrombin Complex Concentrate (PCC) Drug Consumption (2018-2029)
2.4 China Prothrombin Complex Concentrate (PCC) Drug Consumption (2018-2029)
2.5 Europe Prothrombin Complex Concentrate (PCC) Drug Consumption (2018-2029)
2.6 Japan Prothrombin Complex Concentrate (PCC) Drug Consumption (2018-2029)
2.7 South Korea Prothrombin Complex Concentrate (PCC) Drug Consumption (2018-2029)
2.8 ASEAN Prothrombin Complex Concentrate (PCC) Drug Consumption (2018-2029)
2.9 India Prothrombin Complex Concentrate (PCC) Drug Consumption (2018-2029)
3 World Prothrombin Complex Concentrate (PCC) Drug Manufacturers Competitive Analysis
3.1 World Prothrombin Complex Concentrate (PCC) Drug Production Value by Manufacturer (2018-2023)
3.2 World Prothrombin Complex Concentrate (PCC) Drug Production by Manufacturer (2018-2023)
3.3 World Prothrombin Complex Concentrate (PCC) Drug Average Price by Manufacturer (2018-2023)
3.4 Prothrombin Complex Concentrate (PCC) Drug Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Prothrombin Complex Concentrate (PCC) Drug Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Prothrombin Complex Concentrate (PCC) Drug in 2022
3.5.3 Global Concentration Ratios (CR8) for Prothrombin Complex Concentrate (PCC) Drug in 2022
3.6 Prothrombin Complex Concentrate (PCC) Drug Market: Overall Company Footprint Analysis
3.6.1 Prothrombin Complex Concentrate (PCC) Drug Market: Region Footprint
3.6.2 Prothrombin Complex Concentrate (PCC) Drug Market: Company Product Type Footprint
3.6.3 Prothrombin Complex Concentrate (PCC) Drug Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 United States VS China VS Rest of the World
4.1 United States VS China: Prothrombin Complex Concentrate (PCC) Drug Production Value Comparison
4.1.1 United States VS China: Prothrombin Complex Concentrate (PCC) Drug Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Prothrombin Complex Concentrate (PCC) Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Prothrombin Complex Concentrate (PCC) Drug Production Comparison
4.2.1 United States VS China: Prothrombin Complex Concentrate (PCC) Drug Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Prothrombin Complex Concentrate (PCC) Drug Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Prothrombin Complex Concentrate (PCC) Drug Consumption Comparison
4.3.1 United States VS China: Prothrombin Complex Concentrate (PCC) Drug Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Prothrombin Complex Concentrate (PCC) Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Prothrombin Complex Concentrate (PCC) Drug Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Prothrombin Complex Concentrate (PCC) Drug Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Prothrombin Complex Concentrate (PCC) Drug Production Value (2018-2023)
4.4.3 United States Based Manufacturers Prothrombin Complex Concentrate (PCC) Drug Production (2018-2023)
4.5 China Based Prothrombin Complex Concentrate (PCC) Drug Manufacturers and Market Share
4.5.1 China Based Prothrombin Complex Concentrate (PCC) Drug Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Prothrombin Complex Concentrate (PCC) Drug Production Value (2018-2023)
4.5.3 China Based Manufacturers Prothrombin Complex Concentrate (PCC) Drug Production (2018-2023)
4.6 Rest of World Based Prothrombin Complex Concentrate (PCC) Drug Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Prothrombin Complex Concentrate (PCC) Drug Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Prothrombin Complex Concentrate (PCC) Drug Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Prothrombin Complex Concentrate (PCC) Drug Production (2018-2023)
5 Market Analysis by Type
5.1 World Prothrombin Complex Concentrate (PCC) Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Beriplex
5.2.2 Profilnine
5.2.3 Octaplex
5.2.4 Prothromplex
5.2.5 Cofact
5.2.6 Other
5.3 Market Segment by Type
5.3.1 World Prothrombin Complex Concentrate (PCC) Drug Production by Type (2018-2029)
5.3.2 World Prothrombin Complex Concentrate (PCC) Drug Production Value by Type (2018-2029)
5.3.3 World Prothrombin Complex Concentrate (PCC) Drug Average Price by Type (2018-2029)
6 Market Analysis by Application
6.1 World Prothrombin Complex Concentrate (PCC) Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hemophilia B
6.2.2 Acquired Coagulation Factor Deficiency
6.3 Market Segment by Application
6.3.1 World Prothrombin Complex Concentrate (PCC) Drug Production by Application (2018-2029)
6.3.2 World Prothrombin Complex Concentrate (PCC) Drug Production Value by Application (2018-2029)
6.3.3 World Prothrombin Complex Concentrate (PCC) Drug Average Price by Application (2018-2029)
7 Company Profiles
7.1 CSL Behring
7.1.1 CSL Behring Details
7.1.2 CSL Behring Major Business
7.1.3 CSL Behring Prothrombin Complex Concentrate (PCC) Drug Product and Services
7.1.4 CSL Behring Prothrombin Complex Concentrate (PCC) Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 CSL Behring Recent Developments/Updates
7.1.6 CSL Behring Competitive Strengths & Weaknesses
7.2 Grifols
7.2.1 Grifols Details
7.2.2 Grifols Major Business
7.2.3 Grifols Prothrombin Complex Concentrate (PCC) Drug Product and Services
7.2.4 Grifols Prothrombin Complex Concentrate (PCC) Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Grifols Recent Developments/Updates
7.2.6 Grifols Competitive Strengths & Weaknesses
7.3 Octapharma
7.3.1 Octapharma Details
7.3.2 Octapharma Major Business
7.3.3 Octapharma Prothrombin Complex Concentrate (PCC) Drug Product and Services
7.3.4 Octapharma Prothrombin Complex Concentrate (PCC) Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Octapharma Recent Developments/Updates
7.3.6 Octapharma Competitive Strengths & Weaknesses
7.4 Prothya Biosolutions
7.4.1 Prothya Biosolutions Details
7.4.2 Prothya Biosolutions Major Business
7.4.3 Prothya Biosolutions Prothrombin Complex Concentrate (PCC) Drug Product and Services
7.4.4 Prothya Biosolutions Prothrombin Complex Concentrate (PCC) Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Prothya Biosolutions Recent Developments/Updates
7.4.6 Prothya Biosolutions Competitive Strengths & Weaknesses
7.5 Takeda
7.5.1 Takeda Details
7.5.2 Takeda Major Business
7.5.3 Takeda Prothrombin Complex Concentrate (PCC) Drug Product and Services
7.5.4 Takeda Prothrombin Complex Concentrate (PCC) Drug Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Takeda Recent Developments/Updates
7.5.6 Takeda Competitive Strengths & Weaknesses
8 Industry Chain Analysis
8.1 Prothrombin Complex Concentrate (PCC) Drug Industry Chain
8.2 Prothrombin Complex Concentrate (PCC) Drug Upstream Analysis
8.2.1 Prothrombin Complex Concentrate (PCC) Drug Core Raw Materials
8.2.2 Main Manufacturers of Prothrombin Complex Concentrate (PCC) Drug Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Prothrombin Complex Concentrate (PCC) Drug Production Mode
8.6 Prothrombin Complex Concentrate (PCC) Drug Procurement Model
8.7 Prothrombin Complex Concentrate (PCC) Drug Industry Sales Model and Sales Channels
8.7.1 Prothrombin Complex Concentrate (PCC) Drug Sales Model
8.7.2 Prothrombin Complex Concentrate (PCC) Drug Typical Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
Tables and Figures
List of Tables
Table 1. World Prothrombin Complex Concentrate (PCC) Drug Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Prothrombin Complex Concentrate (PCC) Drug Production Value by Region (2018-2023) & (USD Million)
Table 3. World Prothrombin Complex Concentrate (PCC) Drug Production Value by Region (2024-2029) & (USD Million)
Table 4. World Prothrombin Complex Concentrate (PCC) Drug Production Value Market Share by Region (2018-2023)
Table 5. World Prothrombin Complex Concentrate (PCC) Drug Production Value Market Share by Region (2024-2029)
Table 6. World Prothrombin Complex Concentrate (PCC) Drug Production by Region (2018-2023) & (K Units)
Table 7. World Prothrombin Complex Concentrate (PCC) Drug Production by Region (2024-2029) & (K Units)
Table 8. World Prothrombin Complex Concentrate (PCC) Drug Production Market Share by Region (2018-2023)
Table 9. World Prothrombin Complex Concentrate (PCC) Drug Production Market Share by Region (2024-2029)
Table 10. World Prothrombin Complex Concentrate (PCC) Drug Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Prothrombin Complex Concentrate (PCC) Drug Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Prothrombin Complex Concentrate (PCC) Drug Major Market Trends
Table 13. World Prothrombin Complex Concentrate (PCC) Drug Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Prothrombin Complex Concentrate (PCC) Drug Consumption by Region (2018-2023) & (K Units)
Table 15. World Prothrombin Complex Concentrate (PCC) Drug Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Prothrombin Complex Concentrate (PCC) Drug Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Prothrombin Complex Concentrate (PCC) Drug Producers in 2022
Table 18. World Prothrombin Complex Concentrate (PCC) Drug Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Prothrombin Complex Concentrate (PCC) Drug Producers in 2022
Table 20. World Prothrombin Complex Concentrate (PCC) Drug Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Prothrombin Complex Concentrate (PCC) Drug Company Evaluation Quadrant
Table 22. World Prothrombin Complex Concentrate (PCC) Drug Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Prothrombin Complex Concentrate (PCC) Drug Production Site of Key Manufacturer
Table 24. Prothrombin Complex Concentrate (PCC) Drug Market: Company Product Type Footprint
Table 25. Prothrombin Complex Concentrate (PCC) Drug Market: Company Product Application Footprint
Table 26. Prothrombin Complex Concentrate (PCC) Drug Competitive Factors
Table 27. Prothrombin Complex Concentrate (PCC) Drug New Entrant and Capacity Expansion Plans
Table 28. Prothrombin Complex Concentrate (PCC) Drug Mergers & Acquisitions Activity
Table 29. United States VS China Prothrombin Complex Concentrate (PCC) Drug Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Prothrombin Complex Concentrate (PCC) Drug Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Prothrombin Complex Concentrate (PCC) Drug Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Prothrombin Complex Concentrate (PCC) Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Prothrombin Complex Concentrate (PCC) Drug Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Prothrombin Complex Concentrate (PCC) Drug Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Prothrombin Complex Concentrate (PCC) Drug Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Prothrombin Complex Concentrate (PCC) Drug Production Market Share (2018-2023)
Table 37. China Based Prothrombin Complex Concentrate (PCC) Drug Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Prothrombin Complex Concentrate (PCC) Drug Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Prothrombin Complex Concentrate (PCC) Drug Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Prothrombin Complex Concentrate (PCC) Drug Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Prothrombin Complex Concentrate (PCC) Drug Production Market Share (2018-2023)
Table 42. Rest of World Based Prothrombin Complex Concentrate (PCC) Drug Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Prothrombin Complex Concentrate (PCC) Drug Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Prothrombin Complex Concentrate (PCC) Drug Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Prothrombin Complex Concentrate (PCC) Drug Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Prothrombin Complex Concentrate (PCC) Drug Production Market Share (2018-2023)
Table 47. World Prothrombin Complex Concentrate (PCC) Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Prothrombin Complex Concentrate (PCC) Drug Production by Type (2018-2023) & (K Units)
Table 49. World Prothrombin Complex Concentrate (PCC) Drug Production by Type (2024-2029) & (K Units)
Table 50. World Prothrombin Complex Concentrate (PCC) Drug Production Value by Type (2018-2023) & (USD Million)
Table 51. World Prothrombin Complex Concentrate (PCC) Drug Production Value by Type (2024-2029) & (USD Million)
Table 52. World Prothrombin Complex Concentrate (PCC) Drug Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Prothrombin Complex Concentrate (PCC) Drug Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Prothrombin Complex Concentrate (PCC) Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Prothrombin Complex Concentrate (PCC) Drug Production by Application (2018-2023) & (K Units)
Table 56. World Prothrombin Complex Concentrate (PCC) Drug Production by Application (2024-2029) & (K Units)
Table 57. World Prothrombin Complex Concentrate (PCC) Drug Production Value by Application (2018-2023) & (USD Million)
Table 58. World Prothrombin Complex Concentrate (PCC) Drug Production Value by Application (2024-2029) & (USD Million)
Table 59. World Prothrombin Complex Concentrate (PCC) Drug Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Prothrombin Complex Concentrate (PCC) Drug Average Price by Application (2024-2029) & (US$/Unit)
Table 61. CSL Behring Basic Information, Manufacturing Base and Competitors
Table 62. CSL Behring Major Business
Table 63. CSL Behring Prothrombin Complex Concentrate (PCC) Drug Product and Services
Table 64. CSL Behring Prothrombin Complex Concentrate (PCC) Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. CSL Behring Recent Developments/Updates
Table 66. CSL Behring Competitive Strengths & Weaknesses
Table 67. Grifols Basic Information, Manufacturing Base and Competitors
Table 68. Grifols Major Business
Table 69. Grifols Prothrombin Complex Concentrate (PCC) Drug Product and Services
Table 70. Grifols Prothrombin Complex Concentrate (PCC) Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Grifols Recent Developments/Updates
Table 72. Grifols Competitive Strengths & Weaknesses
Table 73. Octapharma Basic Information, Manufacturing Base and Competitors
Table 74. Octapharma Major Business
Table 75. Octapharma Prothrombin Complex Concentrate (PCC) Drug Product and Services
Table 76. Octapharma Prothrombin Complex Concentrate (PCC) Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Octapharma Recent Developments/Updates
Table 78. Octapharma Competitive Strengths & Weaknesses
Table 79. Prothya Biosolutions Basic Information, Manufacturing Base and Competitors
Table 80. Prothya Biosolutions Major Business
Table 81. Prothya Biosolutions Prothrombin Complex Concentrate (PCC) Drug Product and Services
Table 82. Prothya Biosolutions Prothrombin Complex Concentrate (PCC) Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Prothya Biosolutions Recent Developments/Updates
Table 84. Takeda Basic Information, Manufacturing Base and Competitors
Table 85. Takeda Major Business
Table 86. Takeda Prothrombin Complex Concentrate (PCC) Drug Product and Services
Table 87. Takeda Prothrombin Complex Concentrate (PCC) Drug Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 88. Global Key Players of Prothrombin Complex Concentrate (PCC) Drug Upstream (Raw Materials)
Table 89. Prothrombin Complex Concentrate (PCC) Drug Typical Customers
Table 90. Prothrombin Complex Concentrate (PCC) Drug Typical Distributors
List of Figure
Figure 1. Prothrombin Complex Concentrate (PCC) Drug Picture
Figure 2. World Prothrombin Complex Concentrate (PCC) Drug Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Prothrombin Complex Concentrate (PCC) Drug Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Prothrombin Complex Concentrate (PCC) Drug Production (2018-2029) & (K Units)
Figure 5. World Prothrombin Complex Concentrate (PCC) Drug Average Price (2018-2029) & (US$/Unit)
Figure 6. World Prothrombin Complex Concentrate (PCC) Drug Production Value Market Share by Region (2018-2029)
Figure 7. World Prothrombin Complex Concentrate (PCC) Drug Production Market Share by Region (2018-2029)
Figure 8. North America Prothrombin Complex Concentrate (PCC) Drug Production (2018-2029) & (K Units)
Figure 9. Europe Prothrombin Complex Concentrate (PCC) Drug Production (2018-2029) & (K Units)
Figure 10. China Prothrombin Complex Concentrate (PCC) Drug Production (2018-2029) & (K Units)
Figure 11. Japan Prothrombin Complex Concentrate (PCC) Drug Production (2018-2029) & (K Units)
Figure 12. Prothrombin Complex Concentrate (PCC) Drug Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Prothrombin Complex Concentrate (PCC) Drug Consumption (2018-2029) & (K Units)
Figure 15. World Prothrombin Complex Concentrate (PCC) Drug Consumption Market Share by Region (2018-2029)
Figure 16. United States Prothrombin Complex Concentrate (PCC) Drug Consumption (2018-2029) & (K Units)
Figure 17. China Prothrombin Complex Concentrate (PCC) Drug Consumption (2018-2029) & (K Units)
Figure 18. Europe Prothrombin Complex Concentrate (PCC) Drug Consumption (2018-2029) & (K Units)
Figure 19. Japan Prothrombin Complex Concentrate (PCC) Drug Consumption (2018-2029) & (K Units)
Figure 20. South Korea Prothrombin Complex Concentrate (PCC) Drug Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Prothrombin Complex Concentrate (PCC) Drug Consumption (2018-2029) & (K Units)
Figure 22. India Prothrombin Complex Concentrate (PCC) Drug Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Prothrombin Complex Concentrate (PCC) Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Prothrombin Complex Concentrate (PCC) Drug Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Prothrombin Complex Concentrate (PCC) Drug Markets in 2022
Figure 26. United States VS China: Prothrombin Complex Concentrate (PCC) Drug Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Prothrombin Complex Concentrate (PCC) Drug Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Prothrombin Complex Concentrate (PCC) Drug Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Prothrombin Complex Concentrate (PCC) Drug Production Market Share 2022
Figure 30. China Based Manufacturers Prothrombin Complex Concentrate (PCC) Drug Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Prothrombin Complex Concentrate (PCC) Drug Production Market Share 2022
Figure 32. World Prothrombin Complex Concentrate (PCC) Drug Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Prothrombin Complex Concentrate (PCC) Drug Production Value Market Share by Type in 2022
Figure 34. Beriplex
Figure 35. Profilnine
Figure 36. Octaplex
Figure 37. Prothromplex
Figure 38. Cofact
Figure 39. Other
Figure 40. World Prothrombin Complex Concentrate (PCC) Drug Production Market Share by Type (2018-2029)
Figure 41. World Prothrombin Complex Concentrate (PCC) Drug Production Value Market Share by Type (2018-2029)
Figure 42. World Prothrombin Complex Concentrate (PCC) Drug Average Price by Type (2018-2029) & (US$/Unit)
Figure 43. World Prothrombin Complex Concentrate (PCC) Drug Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 44. World Prothrombin Complex Concentrate (PCC) Drug Production Value Market Share by Application in 2022
Figure 45. Hemophilia B
Figure 46. Acquired Coagulation Factor Deficiency
Figure 47. World Prothrombin Complex Concentrate (PCC) Drug Production Market Share by Application (2018-2029)
Figure 48. World Prothrombin Complex Concentrate (PCC) Drug Production Value Market Share by Application (2018-2029)
Figure 49. World Prothrombin Complex Concentrate (PCC) Drug Average Price by Application (2018-2029) & (US$/Unit)
Figure 50. Prothrombin Complex Concentrate (PCC) Drug Industry Chain
Figure 51. Prothrombin Complex Concentrate (PCC) Drug Procurement Model
Figure 52. Prothrombin Complex Concentrate (PCC) Drug Sales Model
Figure 53. Prothrombin Complex Concentrate (PCC) Drug Sales Channels, Direct Sales, and Distribution
Figure 54. Methodology
Figure 55. Research Process and Data Source
Companies Mentioned
CSL Behring
Grifols
Octapharma
Prothya Biosolutions
Takeda
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets